{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-029636","form_type":"8-K","ticker":"DTIL","cik":"0001357874","company_name":"PRECISION BIOSCIENCES INC","filed_at":"2024-03-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.942743+00:00","generated_at":"2026-06-05T05:22:14.923020+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Precision BioSciences prices $40M public offering of 2.5M shares and warrants at $16/unit","bullets":["Offering of 2,500,000 common shares and warrants to purchase another 2,500,000 shares at $16.00 per unit.","Warrants have $20.00 exercise price, are immediately exercisable, and expire in 5 years.","Gross proceeds of $40.0M; net proceeds estimated at ~$37.1M after underwriting discounts.","Proceeds to fund R&D and general corporate purposes; closing expected March 5, 2024.","Participants include Perceptive Advisors, Janus Henderson, Aquilo Capital, LYFE Capital; Guggenheim sole book-runner."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-029636","json":"https://secwatch.observer/filing/0001104659-24-029636.json","markdown":"https://secwatch.observer/filing/0001104659-24-029636.md","text":"https://secwatch.observer/filing/0001104659-24-029636.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1357874/000110465924029636/0001104659-24-029636-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1357874/000110465924029636/tm246680d3_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T05:22:14.923020+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}